REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Colprotein S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing
Full name: Colprotein S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Colprotein S.A. is an enterprise located in Ecuador, with the main office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on August 26, 2015. 8 (2020) employees currently work for Colprotein S.A.. In its most recent financial highlights, the company reported a net sales revenue drop of 7.16% in 2023. There was a total negative growth of 38.41% in Colprotein S.A.’s total assets over the same period.

Headquarters
Av. Galo Plaza Lasso 109 , Floor 106
Quito; Pichincha;

Contact Details: Purchase the Colprotein S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Colprotein S.A. report to view the information.
Outstanding Shares:
Purchase the Colprotein S.A. report to view the information.
Registered Capital:
Purchase the Colprotein S.A. report to view the information.
Incorporation Date:
August 26, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Executive President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Colprotein S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-7.16%▼
Total operating revenue
-0.58%▼
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-38.41%▼
Total equity
-44.77%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.86%▼
Quick Ratio
0.24%▲
Cash Ratio
0.2%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo